Strontium-89 improves survival in advanced prostate cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1274, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer

By Bilen Mehmet Asim   Johnson Marcella M.   Mathew Paul   Pagliaro Lance C.   Araujo John C.   Aparicio Ana   Corn Paul G.   Tannir Nizar M.   Wong Franklin C.   Fisch Michael J.   Logothetis Christopher J.   Tu Shi-Ming  

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 69-76

Blackwell Publishing

Access to resources Recommend Favorite

Androgen suppression improves survival in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Adjuvant androgen suppression improves survival in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 408-419

Bentham Science Publishers

Access to resources Recommend Favorite

Histrelin: In Advanced Prostate Cancer

By Deeks Emma D.  

Drugs, Vol. 70, Iss. 5, 2010-03 ,pp. : 623-630

Adis International

Access to resources Recommend Favorite